The causes of Parkinson's disease (PD) are poorly understood, and so treatment is currently limited to palliative options. Studies of PD have identified both environmental and genetic factors that contribute to the pathophysiology of PD. We will investigate how three PD-related proteins, alpha-synuclein, parkin/KO8E3.7 (the C. elegans homologue of parkin) and DJ-1, affect the toxicity due to inhibition of complex I of the mitochondrial electron transport chain. We will mainly use rotenone as the model toxin for complex I disruption. The three PD-related proteins each have very different putative functions, and how these activities integrate with the pathophysiology of PD is poorly understood. Our preliminary data indicate that expressing alpha-synuclein or deleting KO8E3.7 increases oxidative damage and apoptosis induced by rotenone treatment in C. elegans. In addition, we have identified compounds, D-beta-hydroxybutyrate (a mitochondrial complex II stimulant), tauro-ursodeoxycholic acid (an anti-apoptotic bile acid) and probucol (a potent anti-oxidant), that each partially inhibit rotenone toxicity when applied alone, but in combination prevent rotenone toxicity in C. elegans. In this proposal, we will determine the mechanism of by which alpha- synuclein, parkin/KO8E3.7 and DJ-1 increase mitochondrial damage in both C. elegans and mammalian neurons (primary mouse neuronal cultures and the human neuronal BE-M17 line). We will also determine whether the treatment strategies identified in C. elegans protect mammalian neurons in vitro and in vivo. We hypothesize that mutations in PD-related genes destabilize the mitochondrial electron transport chain leading to an increased tendency to produce free radicals and activate apoptosis. We also hypothesize that combined use of agents that enhance electron transport and inhibit apoptosis (or oxidation) will protect neurons against degenerative processes associated with PD.
Aim 1 will determine whether manipulation of PD-related genes inhibit mitochondrial or proteasomal function, and whether the sensitivity to inhibition increases with age.
Aim 2 will determine whether manipulation of PD-related genes increase apoptosis during rotenone-induced toxicity.
Aim 3 will determine whether combined use of a mitochondrial complex II stimulant plus an apoptotic inhibitor or antioxidant protects neurons against degeneration in transgenic mice carrying the A53T alpha-synuclein transgene.. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
1R01ES015567-01A2
Application #
7145400
Study Section
Special Emphasis Panel (ZRG1-NDBG-A (09))
Program Officer
Lawler, Cindy P
Project Start
2006-08-15
Project End
2011-06-30
Budget Start
2006-08-15
Budget End
2007-06-30
Support Year
1
Fiscal Year
2006
Total Cost
$406,250
Indirect Cost
Name
Boston University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Wolozin, Benjamin; Apicco, Daniel (2015) RNA binding proteins and the genesis of neurodegenerative diseases. Adv Exp Med Biol 822:11-5
Dusonchet, Julien; Li, Hu; Guillily, Maria et al. (2014) A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity. Hum Mol Genet 23:4887-905
Di Domenico, Fabio; Sultana, Rukhsana; Ferree, Andrew et al. (2012) Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease. Antioxid Redox Signal 17:1490-506
Vanderweyde, Tara; Yu, Haung; Varnum, Megan et al. (2012) Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies. J Neurosci 32:8270-83
Ferree, Andrew; Guillily, Maria; Li, Hu et al. (2012) Regulation of physiologic actions of LRRK2: focus on autophagy. Neurodegener Dis 10:238-41
Wolozin, Benjamin; Gabel, Christopher; Ferree, Andrew et al. (2011) Watching worms whither: modeling neurodegeneration in C. elegans. Prog Mol Biol Transl Sci 100:499-514
Chan, Diane; Citro, Allison; Cordy, Joanna M et al. (2011) Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J Biol Chem 286:16140-9
Liu-Yesucevitz, Liqun; Bassell, Gary J; Gitler, Aaron D et al. (2011) Local RNA translation at the synapse and in disease. J Neurosci 31:16086-93
Liu-Yesucevitz, Liqun; Bilgutay, Aylin; Zhang, Yong-Jie et al. (2010) Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One 5:e13250
Hsu, C H; Chan, D; Wolozin, B (2010) LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteins. Neurodegener Dis 7:68-75

Showing the most recent 10 out of 14 publications